Zhejiang Shengda Bio-Pharm Co., Ltd.

Shanghai Stock Exchange 603079.SS

Zhejiang Shengda Bio-Pharm Co., Ltd. Shareholders' Equity for the year ending December 31, 2023: USD 176.72 M

Zhejiang Shengda Bio-Pharm Co., Ltd. Shareholders' Equity is USD 176.72 M for the year ending December 31, 2023, a -8.17% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.

Zhejiang Shengda Bio-Pharm Co., Ltd. Shareholders' Equity for the year ending December 31, 2022 was USD 192.44 M, a -7.40% change year over year.
Zhejiang Shengda Bio-Pharm Co., Ltd. Shareholders' Equity for the year ending December 31, 2021 was USD 207.82 M, a 3.98% change year over year.
Zhejiang Shengda Bio-Pharm Co., Ltd. Shareholders' Equity for the year ending December 31, 2020 was USD 199.87 M, a 57.48% change year over year.
Zhejiang Shengda Bio-Pharm Co., Ltd. Shareholders' Equity for the year ending December 31, 2019 was USD 126.92 M, a 10.32% change year over year.

Key data

Date	Shareholders' Equity	Minority Interest	Total Equity	Total Stockholders Equity and Liabilities

Shanghai Stock Exchange: 603079.SS

Zhejiang Shengda Bio-Pharm Co., Ltd.

CEO	Mr. Bin Zhou
IPO Date	Aug. 23, 2017
Location	China
Headquarters	No. 789, Renmin East Road
Employees	1,032
Sector	Consumers Staples
Industries Pet Food Baby & Childcare Dairy & Milk Fertilizers Frozen Foods Organic Foods Personal Care Plastics

Description

Zhejiang Shengda Bio-Pharm Co., Ltd. engages in the research, development, production, and sale of food and feed additives worldwide. The company offers vitamins, such as biotin and folic acid, etc.; biological fresh-keeping agents, including nisin and natamycin; and intermediate APIs. It also produces natural food preservatives. The company is based in Tiantai, China.

Key trends

Past 5 years